Topical imiquimod versus surgery for vulvar intraepithelial neoplasia: a multicentre, randomised, phase 3, non-inferiority trial

HPV-16 E6/E7 DNA tattoo vaccination using genetically optimized vaccines elicit clinical and immunological responses in patients with usual vulvar intraepithelial neoplasia (uVIN): a phase I/II clinical trial

(2021) Noor Alida Maria Bakker et al.   Journal for ImmunoTherapy of Cancer

Concordance rate of vulvoscopic findings in detecting early vulvar neoplasia

(2020) Frederik A. Stuebs et al.   GYNECOLOGIC ONCOLOGY

A pre‐existing coordinated inflammatory microenvironment is associated with complete response of vulvar high‐grade squamous intraepithelial lesions to different forms of immunotherapy

(2020) Ziena Abdulrahman et al.   INTERNATIONAL JOURNAL OF CANCER

Vulvar intraepithelial neoplasia: Incidence and long‐term risk of vulvar squamous cell carcinoma

(2020) Nikki B. Thuijs et al.   INTERNATIONAL JOURNAL OF CANCER

Real-world effectiveness of Human Papillomavirus vaccination against vulvovaginal high-grade precancerous lesions and cancers

(2020) Christian Dehlendorff et al.   JNCI-Journal of the National Cancer Institute

Impact of smoking on imiquimod response in patients with vulval intraepithelial neoplasia

(2019) G. Harvey et al.   CLINICAL AND EXPERIMENTAL DERMATOLOGY

Risk of cervical and vaginal dysplasia after surgery for vulvar intraepithelial neoplasia or cancer: A 6 year follow-up study

(2019) Tommy R. Buchanan et al.   GYNECOLOGIC ONCOLOGY

Human papillomavirus vaccination coverage, policies, and practical implementation across Europe

(2019) Ngoc-Ha Nguyen-Huu et al.   VACCINE

Vulvar intraepithelial neoplasia: Risk factors for recurrence

(2018) W. Satmary et al.   GYNECOLOGIC ONCOLOGY

Human Papillomavirus Genotypes From Vaginal and Vulvar Intraepithelial Neoplasia in Females 15–26 Years of Age

(2018) Suzanne M. Garland et al.   OBSTETRICS AND GYNECOLOGY

Human Papillomavirus–Induced Squamous Intraepithelial Lesions in Vulvar Lichen Planus

(2016) Sigrid Regauer et al.   Journal of Lower Genital Tract Disease

Sexual Activity, Psychosexual Distress, and Fear of Progression in Women With Human Papillomavirus-Related Premalignant Genital Lesions

(2016) Eva Nagele et al.   Journal of Sexual Medicine

The 2015 International Society for the Study of Vulvovaginal Disease (ISSVD) Terminology of Vulvar Squamous Intraepithelial Lesions

(2016) Jacob Bornstein et al.   OBSTETRICS AND GYNECOLOGY

Does treatment for cervical and vulvar dysplasia impact women’s sexual health?

(2015) Blanca R. Cendejas et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Imiquimod in cervical, vaginal and vulvar intraepithelial neoplasia: A review

(2015) C.J. de Witte et al.   GYNECOLOGIC ONCOLOGY

Activity, safety, and feasibility of cidofovir and imiquimod for treatment of vulval intraepithelial neoplasia (RT3VIN): a multicentre, open-label, randomised, phase 2 trial

(2014) Amanda Tristram et al.   LANCET ONCOLOGY

Clinical Characteristics Associated With Development of Recurrence and Progression in Usual-Type Vulvar Intraepithelial Neoplasia

(2013) Edith M.G. van Esch et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Reliability tests and validation tests of the client satisfaction questionnaire (CSQ-8) as an index of satisfaction with childbirth-related care among Filipino women

(2013) Chieko Matsubara et al.   BMC Pregnancy and Childbirth

Vulvar intraepithelial neoplasia (VIN 2/3): Comparing clinical outcomes and evaluating risk factors for recurrence

(2012) J.J. Wallbillich et al.   GYNECOLOGIC ONCOLOGY

Accuracy of Preoperative Vulva Biopsy and the Outcome of Surgery in Vulvar Intraepithelial Neoplasia 2 and 3

(2009) Stephan Polterauer et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY

Treatment of Vulvar Intraepithelial Neoplasia with Topical Imiquimod

(2008) Manon van Seters et al.   NEW ENGLAND JOURNAL OF MEDICINE